指南与共识关节外科

评估加拿大心血管学会指南在减少全髋关节置换术后心脏事件中的有效性

Evaluation of the Effectiveness of Canadian Cardiovascular Society Guidelines in Minimizing Cardiac Events After Total Hip Arthroplasty.
指南 / 共识 · J Arthroplasty · 2024-06-01

该研究纳入2020年接受择期全髋关节置换术且年龄≥45岁的669例患者,按加拿大心血管学会指南分为4组,评估术后常规肌钙蛋白检测对减少心脏事件的作用。结果显示43例(6.4%)肌钙蛋白升高≥30 ng/L并发生非心脏手术后心肌损伤,其中8例出现心脏并发症、1例发生严重心脏事件导致死亡;实施指南并未显著降低心脏事件发生率或死亡率,且接受术后筛查方案的患者住院时间显著增加。

要点

  • 669例择期全髋关节置换术患者中,43例(6.4%)术后肌钙蛋白升高≥30 ng/L并发生非心脏手术后心肌损伤。
  • 肌钙蛋白升高的患者中,8例出现心脏并发症,1例发生严重心脏事件并导致死亡。
  • 实施加拿大心血管学会指南未显著降低心脏事件发生率或死亡率,但接受术后筛查方案的患者住院时间显著增加。

核心结论

  • 在择期全髋关节置换术中实施加拿大心血管学会指南进行术后常规肌钙蛋白检测,并未显著降低心脏事件发生率或死亡率。

研究设计与样本

  • 研究纳入2020年接受全髋关节置换术的患者,纳入标准为年龄≥45岁的择期全髋关节置换术患者,排除急诊、翻修及同期双侧全髋关节置换术。
  • 共纳入669例患者,平均年龄67岁,根据加拿大心血管学会指南将患者分为4组。

主要发现

  • 669例患者中,43例(6.4%)术后肌钙蛋白水平升高≥30 ng/L并发生非心脏手术后心肌损伤。
  • 肌钙蛋白升高的43例患者中,8例出现心脏并发症,1例发生严重心脏事件并导致死亡。
  • 接受术后筛查方案的患者住院时间显著增加。

关键数值与推荐

  • 术后肌钙蛋白升高阈值定义为≥30 ng/L。
  • 根据加拿大心血管学会指南将患者分为4组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of the study was to analyze the Canadian Cardiovascular Society (CCS) guidelines for routine postoperative troponin testing after elective total hip arthroplasty (THA) to reduce the mortality rate resulting from myocardial injury. The purpose of this study was to assess the prognostic relevance of implementing these guidelines to minimize cardiac events in patients undergoing elective THA. METHODS: Patients who underwent THA surgery in 2020 were included in the study. The inclusion criteria were elective THA patients aged ≥45 years, while emergency, revision, and simultaneous bilateral THA surgeries were excluded. The patients were categorized into 4 groups based on the CCS guidelines. RESULTS: The study included 669 patients who had an average age of 67 years. There were 43 patients (6.4%), who experienced a rise in troponin levels ≥30 ng/L and developed myocardial injury after noncardiac surgery. Among these patients, 8 developed cardiac complications, and one experienced a serious cardiac event that resulted in death. Notably, there was a significant increase in the length of hospital stay for patients who received the postoperative screening protocol. CONCLUSIONS: The implementation of the CCS guidelines for routine postoperative troponin testing in elective THA surgery did not significantly decrease the rate of cardiac events or mortality.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Alatassi R, Somerville LE, Vasarhelyi EM, et al. Evaluation of the Effectiveness of Canadian Cardiovascular Society Guidelines in Minimizing Cardiac Events After Total Hip Arthroplasty. J Arthroplasty. 2024. PMID: 38830433. doi:10.1016/j.arth.2024.05.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。